Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06745609 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prehabilitation Prior to Surgery for Kidney Tumors

Study acronym: Pre-KiT
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Enrollment closed, study ongoing
    • Primary completion date changed from estimate of Mar 2027 to Jun 1, 2026
    • Study completion moved earlier from Mar 2032 to Mar 2031
    • Site details revised
    v3
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 6, 2025 to Jan 21, 2025
    • Site details revised
    v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to examine if one month of general health optimization before surgery for kidney tumors can help participants recover more quickly from surgery. The optimization process is called prehabiliation, and will last one month. It consists of 1. A comprehensive health assessment 2. Assisted smoking cessation 3. A home exercise program. The investigators will compare an intervention group receiving one month of prehabilitation with a control group receiving the standard of care. Some of the main questions the investigators want to answer are * Are participants in the intervention group more satisfied with their quality of recovery after surgery? * Do participants in the intervention group maintain more of their physical abilites compared to the control group?
Trial Details
NCT Number NCT06745609
Lead Sponsor Herlev and Gentofte Hospital
Conditions
(from sponsor)
Renal Cancer, Renal Cell Cancer, Kidney Cancers, Stage I Renal Cell Cancer, Prehabilitation, Elderly (People Aged 65 or More)
Related terms Carcinoma, Renal Cell, Kidney Neoplasms
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov